What Does The Data Behind Jaguar Animal Health, Inc. (NASDAQ:JAGX) Suggest?

Jaguar Animal Health, Inc. (NASDAQ:JAGX) closed its last session at $0.14. The stock traded within a range of $0.140 and $0.160. The company operates in the Healthcare sector with a market capitalization of 15510. Trading volume for Jaguar Animal Health, Inc. was 5.69 Million in its previous trading session. Currently, Jaguar Animal Health, Inc. (NASDAQ:JAGX) has an average volume of 5.12 Million.

Company Profile

Jaguar Health, Inc. is a natural-products pharmaceuticals company. It focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals. The company through its subsidiary Napo Pharmaceuticals Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals. Its product pipeline consists of Mytesi(R), Canalevia(TM), Equilevia(TM) and Neonorm (TM). Jaguar Health Inc., formerly known as Jaguar Animal Health Inc., is based in San Francisco, United States.

Analyst Views

Jaguar Animal Health, Inc. (NASDAQ:JAGX) received a Buy rating from 1 analysts. 0 analysts gave its stock an Outperform rating. 0 analysts say it’s a Hold while 0 analysts provided their expert opinion as Sell.

Jaguar Animal Health, Inc. (NASDAQ:JAGX) touched its 1-Year High price of $1.520 on 02/28/17 and its 1-Year Low price of $0.100 on 11/08/17.

EPS & Financials

Jaguar Animal Health, Inc. (NASDAQ:JAGX) reported its EPS in the last quarter as $-0.06/Share beating the analyst estimate of $-0.13/Share by a difference of $0.07. This showed a surprise of 53.8% in the last quarter earnings.

For the current quarter, 0 analysts are projecting a mean EPS of $0/share. According to their observations and findings, the stock could provide a high EPS of $0/share and a low EPS of $0/share.

Analysts believe that the company has the potential to earn average revenue of $1.35 Million for the current quarter. According to their predictions high & low revenue estimates are 1.35 Million and 1.35 Million respectively.

Technical Analysis

By taking a look at the stock’s current statistics it can gauged that the stock candle is NEUTRAL with HIGH volatility. Jaguar Animal Health, Inc. (NASDAQ:JAGX) has a 20-Day average volume of 9.02 Million. According to today’s trading volume Jaguar Animal Health, Inc. is BELOW its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days.

Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The trend for the past 10-days shows that the company was in BULLISH territory while an analysis of the last 40-Day trend shows a BULLISH signal. The 100-Day trend also shows a BEARISH trend as well.

The company currently has an insider ownership of 2.03 Percent and Institutional ownership of 14.3 Percent. The return on assets stands at -30.2%, Return on Equity currently is -128.7% and the Return on Investment value is -978.1%.

Jaguar Animal Health, Inc. (NASDAQ:JAGX) gross margin percentage stands at 90.8% while its operating margin for the past trailing twelve month is 0 percent and its overall profit margin (ttm) is 0 Percent. The stock is currently moving below its 20-Day Simple Moving Average of -1.34% with a 50-Day Simple Moving Average of 2.72 percent. As of today, the company has a SMA200 (200-day simple moving average) of -63.54 Percent. The Stock has YTD (year to date) performance of 0.83 percent.

The TTM operating margin for the company stands at 0%. The return on invested capital is at -978.1%, which is good, compared to its peers. The Free Cash Flow or FCF margin is 0.

The company’s stock is currently moving with a -ve distance from the 200 day SMA of approximately -63.54%, and has a solid year to date (YTD) performance of 0.83% which means that the stock is constantly adding to its value from the previous fiscal year end price.